Larvol Delta - ACELYRIN-INC-Announces-Magnitude-of-Clinical-Responses-with-Izokibep-in-Psoriatic-Arthritis-Continues-to-Improve-with-Longer-Duration-of-Therapy

izokibep (ABY-035) - Affibody, ACELYRIN

https://www.prnewswire.com/news-releases/acelyrin-inc-announces-magnitude-of-clinical-responses-with-izokibep-in-psoriatic-arthritis-continues-to-improve-with-longer-duration-of-therapy-301793938.html

Apr 12, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next